Anti-TNF therapy (Tumor Necrosis Factor Inhibitors)

Anti-TNF therapy involves medications called Tumor Necrosis Factor (TNF) inhibitors that reduce inflammation by blocking a specific protein called TNF-alpha, which plays a key role in certain autoimmune conditions like rheumatoid arthritis and Crohn’s disease. In these diseases, the immune system mistakenly attacks the body’s tissues, causing pain and damage. By inhibiting TNF-alpha, these drugs help decrease inflammation, alleviate symptoms, and prevent tissue damage. They are typically administered through injections or infusions and are used under medical supervision to manage chronic inflammatory conditions effectively.